Found: 16
Select item for more details and to access through your institution.
Human IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN-γ production.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 10, p. 1727, doi. 10.1007/s00432-012-1248-5
- By:
- Publication type:
- Article
Pharmacological and toxicological studies of a novel goserelin acetate extended-release microspheres in rats.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1125255
- By:
- Publication type:
- Article
Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02029-w
- By:
- Publication type:
- Article
Comparison study of different indoleamine-2,3 dioxygenase inhibitors from the perspective of pharmacodynamic effects.
- Published in:
- International Journal of Immunopathology & Pharmacology, 2020, v. 34, p. 1, doi. 10.1177/2058738420950584
- By:
- Publication type:
- Article
Comparison study of different indoleamine-2,3 dioxygenase inhibitors from the perspective of pharmacodynamic effects.
- Published in:
- International Journal of Immunopathology & Pharmacology, 2020, p. 1, doi. 10.1177/2058738420950584
- By:
- Publication type:
- Article
PCC0208018 exerts antitumor effects by activating effector T cells.
- Published in:
- 2019
- By:
- Publication type:
- Letter
PCC0208018 exerts antitumor effects by activating effector T cells.
- Published in:
- 2019
- By:
- Publication type:
- Letter
PCC0208009 enhances the anti-tumor effects of temozolomide through direct inhibition and transcriptional regulation of indoleamine 2,3-dioxygenase in glioma models.
- Published in:
- International Journal of Immunopathology & Pharmacology, 2018, v. 32, p. 1, doi. 10.1177/2058738418787991
- By:
- Publication type:
- Article
Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model.
- Published in:
- International Journal of Immunopathology & Pharmacology, 2017, v. 30, n. 3, p. 215, doi. 10.1177/0394632017714696
- By:
- Publication type:
- Article
Use of Microscopic Characteristics and Multielemental Fingerprinting Analysis to Trace Three Different Cultivation Modes of Medicinal and Edible Dendrobium officinale in China.
- Published in:
- Biological Trace Element Research, 2023, v. 201, n. 2, p. 1006, doi. 10.1007/s12011-022-03196-5
- By:
- Publication type:
- Article
(+)-9-Trifluoroethoxy-αDihydrotetrabenazine as a Highly Potent Vesicular Monoamine Transporter 2 Inhibitor for Tardive Dyskinesia.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.770377
- By:
- Publication type:
- Article
NSK-01105, a Novel Sorafenib Derivative, Inhibits Human Prostate Tumor Growth via Suppression of VEGFR2/EGFR-Mediated Angiogenesis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0115041
- By:
- Publication type:
- Article
Preparation, Pharmacokinetics, Biodistribution, Antitumor Efficacy and Safety of Lx2-32c-Containing Liposome.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114688
- By:
- Publication type:
- Article
Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2013, v. 2013, p. 1, doi. 10.1155/2013/468537
- By:
- Publication type:
- Article
PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0228339
- By:
- Publication type:
- Article
Research Progress on Targets and Selective Inhibitors of Polo-like Kinase-1 (PLK-1).
- Published in:
- Medicinal Plant, 2024, v. 15, n. 1, p. 51, doi. 10.19600/j.cnki.issn2152-3924.2024.01.013
- By:
- Publication type:
- Article